Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 7/20 | 0.43 |
| ▸ | SRC | P12931 | 2/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 2/20 | 0.42 |
| ▸ | CES1 | P23141 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5282041 | 0.76 | NPSR1 (0.44) | TDP1L3MBTL1LMNASRCNPSR1 | |
| SCHEMBL2543696 | 0.76 | ALDH1A1 (0.63) | LMNANPSR1ALDH1A1TP53SMN1; SMN2 | |
| SCHEMBL20566097 | 0.76 | SRC (0.44) | TDP1L3MBTL1LMNASRCCYP2D6 | |
| SCHEMBL13519347 | 0.74 | ALDH1A1 (0.52) | LMNANPSR1ALDH1A1TP53SMN1; SMN2 | |
| SCHEMBL10870019 | 0.73 | KMT2A (0.38) | LMNAALDH1A1TP53SMN1; SMN2MEN1 | |
| SCHEMBL10695101 | 0.73 | ALDH1A1 (0.43) | LMNANPSR1ALDH1A1TP53SMN1; SMN2 | |
| SCHEMBL2342911 | 0.72 | ALDH1A1 (0.50) | LMNANPSR1ALDH1A1TP53SMN1; SMN2 | |
| SCHEMBL18491075 | 0.72 | ALDH1A1 (0.42) | TDP1L3MBTL1LMNANPSR1ALDH1A1 | |
| SCHEMBL4607473 | 0.72 | ALDH1A1 (0.50) | LMNANPSR1ALDH1A1TP53SMN1; SMN2 | |
| SCHEMBL4607464 | 0.72 | ALDH1A1 (0.50) | LMNANPSR1ALDH1A1TP53SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020019389-A1 | Urea derivative useful as an anti-cancer agent and process for preparing same | CHACONNE NSI CO., LTD. (KR) | 2002-02-14 | — | — | US | disclosed |
| EP-0441226-A1 | (cyanomethyl)pyridines useful as PAF antagonists | J. URIACH & CIA. S.A. (ES) | 1991-08-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020019389-A1 | Urea derivative useful as an anti-cancer agent and process for preparing same | UTS2R, SLC14A1, URB2 | TDP1 3537/4885L3MBTL1 4666/4885LMNA 2239/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.